Assays for diagnosing and evaluating treatment options for Fabry disease
US7851143B2 · kind B2 · utility
54Cited by
10References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 2007 |
| Grant date | Dec 14, 2010 |
| Priority date | — |
| Expiry date | May 16, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are in vitro and in vivo methods for determining whether a patient with Fabry disease will respond to treatment with a specific pharmacological chaperone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.